Alex Martínez‐Martí
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Immunology top 10%
- Cancer Research top 10%
- Co-authors
- Enriqueta FelipS. CedrésAlejandro NavarroPablo MartínezNúria PardoAna VivancosNoemı́ ReguartIrene Sansano
- Topics
- Lung Cancer Treatments and Mutations (35 papers)Cancer Immunotherapy and Biomarkers (33 papers)Lung Cancer Diagnosis and Treatment (22 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Alex Martínez‐Martí
66 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 418
- Immunology 330
- Cancer Research 272
Countries citing papers authored by Alex Martínez‐Martí
This map shows the geographic impact of Alex Martínez‐Martí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Martínez‐Martí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Martínez‐Martí more than expected).
Fields of papers citing papers by Alex Martínez‐Martí
This network shows the impact of papers produced by Alex Martínez‐Martí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Martínez‐Martí. The network helps show where Alex Martínez‐Martí may publish in the future.
Co-authorship network of co-authors of Alex Martínez‐Martí
This figure shows the co-authorship network connecting the top 25 collaborators of Alex Martínez‐Martí. A scholar is included among the top collaborators of Alex Martínez‐Martí based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Martínez‐Martí. Alex Martínez‐Martí is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 3 | |
| 4 | Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trialbreakdown → | 126 |
| 5 | 4 | |
| 6 | 4 | |
| 7 | 16 | |
| 8 | 7 | |
| 9 | 6 | |
| 10 | 49 | |
| 11 | 10 | |
| 12 | 19 | |
| 13 | 10 | |
| 14 | 8 | |
| 15 | 1 | |
| 16 | 102 | |
| 17 | 61 | |
| 18 | 277 | |
| 19 | 7 | |
| 20 | 55 |
About Alex Martínez‐Martí
Alex Martínez‐Martí is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 71 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), Cancer Immunotherapy and Biomarkers (33 papers) and Lung Cancer Diagnosis and Treatment (22 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Cancer Research (272 citations). Alex Martínez‐Martí has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Enriqueta Felip, S. Cedrés, Alejandro Navarro, Pablo Martínez, Núria Pardo, Ana Vivancos, Noemı́ Reguart, Irene Sansano, Santiago Ponce-Aix and Ana B. Enguita. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.